Ivabradine Intermediate Synthesis via Palladium-Catalyzed Coupling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing (2E)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, a key intermediate in the production of ivabradine, suffer from low yields, which hampers the industrial production of this pharmacologically valuable compound.

Innovation Solution

A process involving a coupling reaction of compound IX with acrylonitrile in the presence of a palladium catalyst, a ligand, a base, and a phase transfer agent in an organic solvent, specifically using palladium on carbon, tri(o-tolyl)phosphine, sodium acetate, and tetrabutylammonium bromide in N,N-dimethylacetamide, at temperatures between 100°C and 170°C, to achieve the desired product with improved yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods are used to synthesize (2E)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, then the synthesis process can be carried out with simple procedures, but the yield is low which hampers industrial production

Engineering Contradiction:
ImproveyieldVSAvoidprocess complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent introduces a phase transfer catalyst as an intermediary substance that mediates between the organic substrate and inorganic base, enabling efficient carbon-carbon bond formation. The phase transfer catalyst facilitates the transfer of reactants between phases, significantly improving the yield of the coupling reaction without requiring complex process conditions

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent optimizes reaction parameters including temperature, solvent type, catalyst loading, and base selection to maximize yield. By systematically adjusting these parameters, the process achieves high productivity while maintaining reasonable process complexity suitable for industrial scaling

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If conventional synthesis methods are used, then the process steps are straightforward, but the low yield results in material loss and increased production costs

Engineering Contradiction:
ImproveyieldVSAvoidmaterial loss
Core Design Contradiction:
Quantity of substanceVSLoss of substance

Solution Approach 1:

The phase transfer catalyst acts as a mediator that enables complete conversion of reactants to products by facilitating efficient interaction between organic and inorganic phases. This eliminates material loss associated with incomplete reactions while maintaining straightforward process conditions

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs reaction conditions that minimize byproduct formation and facilitate easy separation of products from reaction mixtures. The phase transfer catalyst and other reagents can be recovered or disposed of efficiently, reducing overall material loss in the synthesis process

Inventive Principle:
Principle #34Discarding and recovering

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process significantly enhances the yield of (2E)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile, facilitating the efficient synthesis of ivabradine and its salts, which are crucial for treating myocardial ischemia and arrhythmias, thereby addressing the limitations of previous methods.

Implementation Method 1

the compound of formula (IX) is subjected to a coupling reaction with acrylonitrile in the presence of a palladium catalyst, a ligand, a base and a phase transfer agent

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentEP2730562B1Novel method for synthesising (2E)-3-(3,4-dimethoxyphenyl)prop-2-enenitrile and use for synthesising ivabradine and the added salts thereof with a pharmaceutically acceptable acid
Publication Date: 2015.03.25 LES LAB SERVIER SA
  • EP2730562B1 patent drawing
  • EP2730562B1 patent drawing
  • EP2730562B1 patent drawing

AI summary

Synthesis process of the compound of formula (I): Application to the synthesis of ivabradine, its addition salts to a pharmaceutically acceptable acid and its hydrates.